Article Information
History
- May 16, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Florian Lüke1,2,3,*,
- Florian Haller4,5,
- Kirsten Utpatel2,6,
- Markus Krebs7,8,
- Norbert Meidenbauer5,9,
- Alexander Scheiter2,6,10,
- Silvia Spörl5,9,
- Daniel Heudobler1,2,10,
- Felix Keil2,6,
- Christoph Schubart4,5,
- Lars Tögel4,5,
- Sabine Einhell1,2,
- Wolfgang Dietmaier2,6,
- Ralf Huss11,12,
- Sebastian Dintner11,12,
- Sebastian Sommer12,13,
- Frank Jordan12,13,
- Maria-Elisabeth Goebeler7,14,
- Michaela Metz7,
- Diana Haake7,
- Mithun Scheytt7,
- Elena Gerhard-Hartmann7,15,
- Katja Maurus7,15,
- Stephanie Brändlein7,15,
- Andreas Rosenwald7,15,
- Arndt Hartmann4,5,
- Bruno Märkl11,12,
- Hermann Einsele10,14,
- Andreas Mackensen5,9,10,
- Wolfgang Herr1,2,
- Volker Kunzmann7,14,
- Ralf Bargou7,10,
- Matthias W. Beckmann5,10,15,
- Tobias Pukrop1,2,3,10,
- Martin Trepel10,12,13,
- Matthias Evert2,6,
- Rainer Claus11,12,13 and
- Alexander Kerscher7
- 1Department of Internal Medicine III, University Hospital Regensburg, Hematology and Oncology, Regensburg, Germany
- 2Comprehensive Cancer Center Ostbayern, Regensburg, Germany
- 3Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany
- 4Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany
- 5Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
- 6Institute of Pathology, University of Regensburg, Regensburg, Germany
- 7Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
- 8Department of Urology and Pediatric Urology, University Hospital Würzburg, Würzburg, Germany
- 9Department of Medicine V, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
- 10Bavarian Center for Cancer Research / BZKF, Bavaria, Germany
- 11Institute of Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany
- 12Comprehensive Cancer Center Augsburg, Augsburg, Germany
- 13Department of Hematology and Clinical Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany
- 14Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
- 15Institute of Pathology, University of Würzburg, Würzburg, Germany
- 16Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
- ↵*Corresponding author; email: florian.lueke{at}ukr.de
Posted May 16, 2022.
Mapping the Regional Distribution of Molecular Tumor Board Patients and Identifying White Spots in our Catchment Area – a Joint Approach of the CCC WERA Alliance
